Explore more publications!
Alabama STEM News
Submit Press Release

Alabama STEM News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alabama STEM News.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 13, 2025

Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer
October 13, 2025

Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer

Indeterminate GlobeNewswire
Myseum Awarded Israeli Patent for Advanced Digital Privacy Technology
October 13, 2025

Myseum Awarded Israeli Patent for Advanced Digital Privacy Technology

Indeterminate GlobeNewswire
Third Millennium Unveils Multi-Technology Readers Combining Card and QR Code Access in One Device
October 13, 2025

Third Millennium Unveils Multi-Technology Readers Combining Card and QR Code Access in One Device

Indeterminate GlobeNewswire
Auron Therapeutics to Participate in the 8th Annual Targeted Protein Degradation & Induced Proximity Summit
October 13, 2025

Auron Therapeutics to Participate in the 8th Annual Targeted Protein Degradation & Induced Proximity Summit

Indeterminate GlobeNewswire
Evaxion to present a breadth of data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025
October 13, 2025

Evaxion to present a breadth of data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025

Indeterminate GlobeNewswire
SELLAS Life Sciences to Present In Vivo Preclinical Data Demonstrating Statistically Significant Survival Benefit of SLS009 in T-Cell Prolymphocytic Leukemia at the European Society for Medical Oncology (ESMO) Congress 2025
October 13, 2025

SELLAS Life Sciences to Present In Vivo Preclinical Data Demonstrating Statistically Significant Survival Benefit of SLS009 in T-Cell Prolymphocytic Leukemia at the European Society for Medical Oncology (ESMO) Congress 2025

Indeterminate GlobeNewswire
Compliance & Risks Launches AI Sustainability Platform
October 13, 2025

Compliance & Risks Launches AI Sustainability Platform

Indeterminate GlobeNewswire
Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing
October 13, 2025

Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing

Indeterminate GlobeNewswire
Hinge Bio Announces FDA Clearance of Investigational New Drug Application for HB2198, a Novel B cell-Depleting Agent, for Patients with Systemic Lupus Erythematosus and Lupus Nephritis
October 13, 2025

Hinge Bio Announces FDA Clearance of Investigational New Drug Application for HB2198, a Novel B cell-Depleting Agent, for Patients with Systemic Lupus Erythematosus and Lupus Nephritis

Indeterminate GlobeNewswire
HMNC Brain Health Presents New Analysis Supporting Rationale for Combining a Genetic Patient Selection Tool with a Vasopressin V1b Receptor Antagonist in the Treatment of Depression at ISCTM Conference in Amsterdam
October 13, 2025

HMNC Brain Health Presents New Analysis Supporting Rationale for Combining a Genetic Patient Selection Tool with a Vasopressin V1b Receptor Antagonist in the Treatment of Depression at ISCTM Conference in Amsterdam

Indeterminate GlobeNewswire
Cidara Therapeutics to Present Late-Breaking Clinical Phase 2 Data on CD388 at ID Week 2025
October 13, 2025

Cidara Therapeutics to Present Late-Breaking Clinical Phase 2 Data on CD388 at ID Week 2025

Indeterminate GlobeNewswire
MKS Inc. Announces Third Quarter 2025 Earnings Conference Call
October 13, 2025

MKS Inc. Announces Third Quarter 2025 Earnings Conference Call

Indeterminate GlobeNewswire
Nuvini Announces Open-Market Stock Purchases by Key Executives
October 13, 2025

Nuvini Announces Open-Market Stock Purchases by Key Executives

Indeterminate GlobeNewswire
4DMT Advances 4D-710 to Phase 2 with Additional Funding and Support from the Cystic Fibrosis Foundation
October 13, 2025

4DMT Advances 4D-710 to Phase 2 with Additional Funding and Support from the Cystic Fibrosis Foundation

Indeterminate GlobeNewswire
Theriva™ Biologics Announces Upcoming Presentations at Medical Meetings
October 13, 2025

Theriva™ Biologics Announces Upcoming Presentations at Medical Meetings

Indeterminate GlobeNewswire
Theriva™ Biologics anuncia próximas ponencias en congresos médicos
October 13, 2025

Theriva™ Biologics anuncia próximas ponencias en congresos médicos

Indeterminate GlobeNewswire
Connect Appoints Tre Braquet as Chief Brand & Engagement Officer
October 13, 2025

Connect Appoints Tre Braquet as Chief Brand & Engagement Officer

Indeterminate GlobeNewswire
Soleno Therapeutics Appoints Biopharmaceutical Executive Mark W. Hahn to its Board of Directors
October 13, 2025

Soleno Therapeutics Appoints Biopharmaceutical Executive Mark W. Hahn to its Board of Directors

Indeterminate GlobeNewswire
Immutep Announces Successful Completion of FDA Project Optimus Requirements
October 13, 2025

Immutep Announces Successful Completion of FDA Project Optimus Requirements

Indeterminate GlobeNewswire
Apyx Medical Corporation Submits FDA 510(k) for Device Label Expansion of AYON Body Contouring System™ for Power Liposuction
October 13, 2025

Apyx Medical Corporation Submits FDA 510(k) for Device Label Expansion of AYON Body Contouring System™ for Power Liposuction

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions